Back to Awarded Treatment Trials
Awarded Trial: 09T-002
Grant ID
09T-002
Illness
Schizophrenia
Primary Drug/Intervention
Mirtazapine
Primary Dosage
30 mg/day
Secondary Drug Intervention
Folate
Secondary Dosage
400-500 micrograms/day
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Terminated
Investigator
Geddes, et al.
Sample Size
330
Duration of Study Period for Each Subject
12 weeks
Outcome Measurements
N/A
Results
N/A
Publication
N/A
Link
N/A
PI Name
John Geddes, et al.
Degree
MD
Center
N/A
Institution
N/A
Address
Warneford Hospital
City or Town
Oxford
State or Province
OX ON
Zip or Postal Code
OX10 ORU
Country
United Kingdom
Email Address
john.geddes@psych.ox.ac.uk